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sulfatases have a common structural feature essentialA Major Step on the Road to
for their catalytic activity. All sulfatase activities areUnderstanding a Unique markedly decreased in patients with MSD. Furthermore,
patients with MSD have features characteristic of meta-Posttranslational Modification
chromatic leukodystrophy, mucopolysaccharidoses,and Its Role in a Genetic Disease
X-linked ichthyosis, and chondrodysplasia punctata
(Hopwood and Ballabio, 2001) consistent with the ab-
sence of multiple sulfatase activities. Evidence that a
second gene is required for producing active sulfatasesThe posttranslational conversion of cysteine to C-
and is defective in MSD was obtained by somatic cellformylglycine in the catalytic site of mammalian sul-
hydridization studies using cell lines from patients withfatases is deficient in the rare but devastating disorder
single sulfatase deficiencies and MSD (Ballabio and Par-multiple sulfatase deficiency (MSD). Two papers in this
enti, 1985). Cultured cells from MSD patients produceissue of Cell (Dierks et al., 2003; Cosma et al., 2003)
normal amounts of sulfatase polypeptides that are cata-report the cloning of a gene responsible for this ac-
lytically inactive. Expression of sulfatase cDNAs in MSDtivity.
fibroblasts yielded sulfatases with little activity as com-
pared to expression of the same sulfatases in fibroblastsSulfatases are a family of structurally related enzymes
from patients with single sulfatase deficiencies. In anthat catalyze the hydrolysis of O- and N-sulfate esters
earlier study published in Cell (Schmidt et al., 1995),that are found on glycosaminoglycans, glycopeptides,
von Figura and colleagues determined that a cysteineglycolipids, and hydroxysteroids. Two groups lead by
residue that is conserved in the sequence of all sul-Kurt von Figura (Dierks et al., 2003) and Andrea Ballabio
fatases is replaced by a C-formylglycine in arylsulfa-(Cosma et al., 2003) have filled in a key step in an intri-
tases A and B from normal but not from MSD fibroblasts.guing journey that began with the realization that all
This same group has extensively characterized theeukaryotic and prokaryotic sulfatases have a common
properties of the formylglycine generating enzyme (FGE)form of posttranslational modification in the catalytic
using innovative in vitro assays. FGE is a soluble enzymesite that results in the formation of a C-formylglycine
located in the endoplasmic reticulum that acts to con-(Schmidt et al.,1995). The C-formylglycine, present in
vert cysteine to formylglycine either co- or posttransla-the form of an aldehyde hydrate, is essential for catalytic
tionally prior to folding of the protein. In the currentactivity because it forms a covalent intermediate with
paper, Dierks et al. (2003) have developed a rapid assaythe sulfate following nucleophilic attack by one of its
for FGE using a peptide substrate and analysis byhydroxyl groups and release by elimination mediated
MALDI-TOF that allowed them to purify FGE from aby its other hydroxyl group (von Figura et al., 1998).
soluble fraction prepared from bovine testis. The same
These investigators have taken elegant biochemical and
peptide with the Cys substituted by Ser was used as
genetic approaches, respectively, to identify the gene(s)
an effective affinity matrix. Peptide sequence analysis
responsible for the conversion of Cys to C-formylgly- led to the identification of the gene encoding FGE; this
cine in vertebrate sulfatases. gene on chromosome 3p26 has been denoted SUMF1
Thirteen genes encoding sulfatases that differ in (sulfatase modifying factor 1). Cosma et al. (2003) used
structure, specificity, and/or expression have been iden- microcell-mediated chromosome transfer and func-
tified in vertebrates (Parenti et al., 1997). Eight of the tional complementation to identify the same gene,
sulfatases are found in lysosomes and serve to remove SUMF1, as defective in MSD patients.
sulfate from glycosaminoglycans, glycopeptides, and The cDNA encoding human FGE predicts a protein
glycolipids. The other sulfatases, which are active with 374 amino acids, a cleavable signal sequence, and
against hydroxysteroids, are found in microsomes, en- a single Asn glycosylation site. The absence of the endo-
doplasmic reticulum, and Golgi. Genetic deficiencies of plasmic reticulum retention sequence KDEL indicates
individual sulfatases reveal the critical importance of that a different mechanism for retention in the endoplas-
each of these enzymes in the metabolism of specific mic reticulum is utilized. When expressed in cultured
forms of sulfate. Deficiencies of lysosomal sulfatases fibroblasts, epitope-tagged FGE nonetheless localizes
that act on glycosaminoglycans and glycolipids account to the endoplasmic reticulum. Sequencing of FGE
for the mucopolysaccharidoses and metachromatic leu- cDNAs from 7 MSD patients has yielded 9 different mu-
kodystrophy, respectively. X-linked ichthyosis is caused tations. Furthermore, expression of wild-type FGE but
by a deficiency of the non-lysosomal sulfatase arylsulfa- not FGE carrying MSD mutations increases sulfatase
tase C while chondrodysplasia punctata is caused by a activities in fibroblasts from MSD patients 2- to 5-fold.
deficiency of another non-lysosomal sulfatase, arylsul- Remarkably, coexpression of FGE and sulfatase cDNAs
fatase E. Characteristic of each of these deficiencies is in cultured cells results in a 50-fold increase in sulfatase
a specific clinical phenotype and the accumulation of levels. FGE appears to be both essential and limiting
small sulfated compounds reflecting the specificity of for the synthesis of catalytically active sulfatases. This
the absent sulfatase. observation has important implications for the produc-
The rare autosomal recessive disorder multiple sul- tion of active recombinant sulfatases for replacement
therapies and for gene therapies.fatase deficiency (MSD) provided the first indication that
Cell
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A paralog designated SUMF2 was also identified. Both Fusion with the Fused: A New Role
groups indicate that it may have some capacity to acti- for Interleukin-4 in the Buildingvate sulfatases but is significantly less active than
SUMF1. Whether SUMF2 or residual activity on the part of Muscle
of mutant forms of SUMF1 account for residual sulfatase
activities in MSD cells remains to be determined. SUMF1
and SUMF2 appear to have evolved independently;
In this issue of Cell, G. Pavlath and coworkers (Horsleyhowever, all vertebrate species examined have homo-
et al., 2003) demonstrate a novel role for Interleukin-logs for both genes.
4 (IL-4) in regulating the fusion of myoblasts with differ-While these studies represent a major advance in our
entiated myotubes. The authors demonstrate thatunderstanding of sulfatases, they also raise many new
NFATc2 signaling in newly formed myotubes inducesquestions. Are there other proteins that contain a
IL-4 expression and secretion which promotes myo-C-formylglycine moiety? How do SUMF1 and SUMF2
blast fusion with pre-existing myotubes.differ with respect to specificity, activity, and expres-
sion? What are the consequences of these differences?
How are the FGEs retained in the endoplasmic reticu-
lum? Will tissue specific levels of SUMF1 expression The regulation of skeletal muscle mass is an important
have an impact on gene replacement therapies for indi- adaptive response to both physical and pathological
vidual sulfatase deficiencies? The identification of stimuli. Skeletal muscle mass is principally controlled
SUMF1 and SUMF2 as genes responsible for the synthe- through the regulation of myofiber size. The myofibers
sis of C-formylglycine from cysteine will lead to addi- are the basic contractile unit of skeletal muscle and
tional insights into the biology of sulfatases and their being a syncitium, their size can be modulated by two
sulfated substrates. Defining the molecular basis for distinct mechanisms. First, the cytoplasmic volume as-
genetic diseases such as MSD continues to provide a sociated with individual myonuclei is regulated. This
path to understanding the often complex role of post- pathway appears to involve regulation of protein synthe-
translational modification. sis, through PI3K signaling, and of protein degradation,
through muscle-specific ubiquitin ligases (Schiaffino
and Serrano, 2002). Second, the number of myonucleiJacques U. Baenziger
within a myofiber also determines myofiber size. ForDepartment of Pathology
example, during atrophy, the myonuclei are lost, possi-Washington University School of Medicine
bly through apoptotic-like mechanisms whereas during660 S. Euclid Avenue
postnatal growth and hypertrophy, the myoblasts (mo-St. Louis, Missouri 63110
nonucleated muscle cells) proliferate and fuse to exist-
Selected Reading ing myofibers (Schiaffino and Serrano, 2002). Several
growth factors have been implicated in the activation
Ballabio, A., Parenti, G., Napolitano, E., Di Natale, P., and Andria, of myoblasts to proliferate, amongst which insulin-like
G. (1985). Hum. Genet. 70, 315–317.
growth factor 1 (IGF-1) is a strong candidate promoting
Cosma, M.P., Pepe, S., Annunziata, I., Newbold, R.F., Grompe, M.,
muscle hypertrophy (Hawke and Garry, 2001). However,Parenti, G., and Ballabio, A. (2003). Cell 113, this issue, 445–456.
the mechanisms controlling myoblast fusion, whetherDierks, T., Schmidt, B., Borissenko, L., Peng, J., Preusser, A., Mari-
associated with postnatal muscle growth or in responseappan, M., and von Figura, K. (2003). Cell 113, this issue, 435–444.
to injury, have remained elusive.Hopwood, J.J., and Ballabio, A. (2001). Multiple sulfatase deficiency
Regulation of intracellular calcium concentrations isand the nature of the sulfatase family. In The Metabolic and Molecu-
lar Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, D. Valle, crucial in controlling various cell signaling pathways.
and W.S. Sly, eds. (New York: McGraw-Hill), pp. 3725–3732. Calcineurin, a ubiquitous calcium-activated serine/thre-
Parenti, G., Meroni, G., and Ballabio, A. (1997). Curr. Opin. Genet. onine phosphatase comprising a catalytic subunit, a
Dev. 7, 386–391. regulatory subunit, and calmodulin (a calcium sensor)
Schmidt, B., Selmer, T., Ingendoh, A., and von Figura, K. (1995). Cell is a major mediator of Ca2 signaling in different cell
82, 271–278. systems. Activated calcineurin regulates gene expres-
von Figura, K., Schmidt, B., Selmer, T., and Dierks, T. (1998). Bioes- sion through dephosphorylation of a family of transcrip-
says 20, 505–510. tion factors known as nuclear factors of activated T cells
(NF-ATs) comprising NF-ATc1, NF-ATc2, NF-ATc3, and
NF-ATc4. Following dephosphorylation, NF-AT translo-
cates to the nucleus and activates target genes in coop-
eration with specific transcription factors. Specific NF-
AT isoforms are highly expressed in skeletal muscle and
in vitro analyses have demonstrated their differential
translocation from the cytoplasm to the nucleus at differ-
ent stages of myoblast differentiation, suggesting spe-
cific roles for these transcription factors during myo-
genic differentiation (Abbott et al., 1998).
In vitro and in vivo analyses have implicated NF-ATs
in the regulation of muscle hypertrophy and fiber type
specification. Inhibition of calcineurin by injection of
